Ramon Arens

27PUBLICATIONS
80CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jul 31, 2026
Dendritic cell circadian clocks shape memory CD8+ T cell differentiation.

|Feb 23, 2026
B cells maintain the homeostasis of splenic marginal zone antigen-presenting cells to promote the antiviral CD8+ T-cell response.

Xinyuan Liu, Filiz Demircik, Mariia Antipova

|Jan 19, 2026
Cell cycle arrest enhances CD8+ T cell effector function by potentiating glucose metabolism and IL-2 signaling.

Floortje J van Haften, Tetje C van der Sluis, Hanna S Hepp

|Jan 03, 2024
T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors.

Jim Middelburg, Marjolein Sluijter, Gaby Schaap

|Nov 29, 2023
Delayed vaccine-induced CD8+ T cell expansion by topoisomerase I inhibition mediates enhanced CD70-dependent tumor eradication.

Tetje C van der Sluis, Floortje J van Haften, Suzanne van Duikeren

|Aug 03, 2022
CRISPR Activation Screening Identifies VGLL3-TEAD1-RUNX1/3 as a Transcriptional Complex for PD-L1 Expression.

Ruud H Wijdeven, Birol Cabukusta, Felix M Behr

Pageof 5

Frequent Collaborators

5 joint publications

Sjoerd H van der Burg

4 joint publications

Thorbald Van Hall

4 joint publications

Felix M Behr

3 joint publications

Jan Willem Kleinovink